These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18632611)

  • 1. PIK3IP1, a negative regulator of PI3K, suppresses the development of hepatocellular carcinoma.
    He X; Zhu Z; Johnson C; Stoops J; Eaker AE; Bowen W; DeFrances MC
    Cancer Res; 2008 Jul; 68(14):5591-8. PubMed ID: 18632611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PIK3IP1: structure, aberration, function, and regulation in diseases.
    Jia Y; He P; Ma X; Lv K; Liu Y; Xu Y
    Eur J Pharmacol; 2024 Aug; 977():176753. PubMed ID: 38897445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PI3K is negatively regulated by PIK3IP1, a novel p110 interacting protein.
    Zhu Z; He X; Johnson C; Stoops J; Eaker AE; Stoffer DS; Bell A; Zarnegar R; DeFrances MC
    Biochem Biophys Res Commun; 2007 Jun; 358(1):66-72. PubMed ID: 17475214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metallothionein expression is suppressed in primary human hepatocellular carcinomas and is mediated through inactivation of CCAAT/enhancer binding protein alpha by phosphatidylinositol 3-kinase signaling cascade.
    Datta J; Majumder S; Kutay H; Motiwala T; Frankel W; Costa R; Cha HC; MacDougald OA; Jacob ST; Ghoshal K
    Cancer Res; 2007 Mar; 67(6):2736-46. PubMed ID: 17363595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
    Frau M; Feo F; Pascale RM
    J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pik3ip1 modulates cardiac hypertrophy by inhibiting PI3K pathway.
    Song HK; Kim J; Lee JS; Nho KJ; Jeong HC; Kim J; Ahn Y; Park WJ; Kim DH
    PLoS One; 2015; 10(3):e0122251. PubMed ID: 25826393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma.
    Castro-Sánchez L; Agra N; Llorente Izquierdo C; Motiño O; Casado M; Boscá L; Martín-Sanz P
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2501-11. PubMed ID: 23954207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
    Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of histone demethylase KDM3A-dependent AP-1 transactivity on hepatotumorigenesis induced by PI3K activation.
    Nakatsuka T; Tateishi K; Kudo Y; Yamamoto K; Nakagawa H; Fujiwara H; Takahashi R; Miyabayashi K; Asaoka Y; Tanaka Y; Ijichi H; Hirata Y; Otsuka M; Kato M; Sakai J; Tachibana M; Aburatani H; Shinkai Y; Koike K
    Oncogene; 2017 Nov; 36(45):6262-6271. PubMed ID: 28692045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
    Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
    Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat shock protein 22 (HSPB8) reduces the migration of hepatocellular carcinoma cells through the suppression of the phosphoinositide 3-kinase (PI3K)/AKT pathway.
    Matsushima-Nishiwaki R; Toyoda H; Takamatsu R; Yasuda E; Okuda S; Maeda A; Kaneoka Y; Yoshimi N; Kumada T; Kozawa O
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1629-1639. PubMed ID: 28456666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KDM5A silencing transcriptionally suppresses the FXYD3-PI3K/AKT axis to inhibit angiogenesis in hepatocellular cancer via miR-433 up-regulation.
    Ma YS; Wu TM; Qian B; Liu YS; Ding H; Fan MM; Liu JB; Yu F; Wang HM; Shi Y; Gu LP; Li L; Tian LL; Wang PY; Wang GR; Wu ZJ; Zou QF; Ling CC; Fu D
    J Cell Mol Med; 2021 Apr; 25(8):4040-4052. PubMed ID: 33621431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target.
    Chen H; Wong CC; Liu D; Go MYY; Wu B; Peng S; Kuang M; Wong N; Yu J
    Theranostics; 2019; 9(18):5246-5260. PubMed ID: 31410213
    [No Abstract]   [Full Text] [Related]  

  • 14. Elevated PDK1 Expression Drives PI3K/AKT/MTOR Signaling Promotes Radiation-Resistant and Dedifferentiated Phenotype of Hepatocellular Carcinoma.
    Bamodu OA; Chang HL; Ong JR; Lee WH; Yeh CT; Tsai JT
    Cells; 2020 Mar; 9(3):. PubMed ID: 32197467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.
    Qiu FN; Huang Y; Chen DY; Li F; Wu YA; Wu WB; Huang XL
    World J Gastroenterol; 2016 Apr; 22(16):4226-37. PubMed ID: 27122673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The oncoprotein HBXIP suppresses gluconeogenesis through modulating PCK1 to enhance the growth of hepatoma cells.
    Shi H; Fang R; Li Y; Li L; Zhang W; Wang H; Chen F; Zhang S; Zhang X; Ye L
    Cancer Lett; 2016 Nov; 382(2):147-156. PubMed ID: 27609066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma.
    Huang JL; Cao SW; Ou QS; Yang B; Zheng SH; Tang J; Chen J; Hu YW; Zheng L; Wang Q
    Mol Cancer; 2018 May; 17(1):93. PubMed ID: 29803224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrin alpha 7 correlates with poor clinical outcomes, and it regulates cell proliferation, apoptosis and stemness via PTK2-PI3K-Akt signaling pathway in hepatocellular carcinoma.
    Ge JC; Wang YX; Chen ZB; Chen DF
    Cell Signal; 2020 Feb; 66():109465. PubMed ID: 31698037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic Akt-FOXO3 loop favors tumor-promoting modes and enhances oxidative damage-associated hepatocellular carcinogenesis.
    Lu M; Hartmann D; Braren R; Gupta A; Wang B; Wang Y; Mogler C; Cheng Z; Wirth T; Friess H; Kleeff J; Hüser N; Sunami Y
    BMC Cancer; 2019 Sep; 19(1):887. PubMed ID: 31488102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of T-cell activation by PIK3IP1.
    DeFrances MC; Debelius DR; Cheng J; Kane LP
    Eur J Immunol; 2012 Oct; 42(10):2754-9. PubMed ID: 22706993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.